Regeneron Pharmaceuticals, Inc.
High affinity human antibodies to human angiopoietin-2
Last updated:
Abstract:
The present invention provides antibodies that bind to angiopoietin-2 (Ang-2) and methods of using same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to human Ang-2. The antibodies of the invention are useful, inter alia, for the treatment of diseases and disorders associated with one or more Ang-2 biological activities including angiogenesis.
Status:
Grant
Type:
Utility
Filling date:
28 Feb 2018
Issue date:
29 Dec 2020